1276.HK
1276.HK
CNE100006XS6
HENGRUI PHARMA
Loading chart...

Company Profile

Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.

Related stocks

600276.SS
600276.SS • China
JIANGSU HENGRUI PHARMACEUTICALS
46.85 CNY
46.53B USD 1Y -34.2%
688506.SS
688506.SS • China
SICHUAN BIOKIN PHARMACEUTICAL C
229.33 CNY
14.17B USD 1Y -37.4%
000538.SZ
000538.SZ • China
YUNNAN BAIYAO
51.4 CNY
13.72B USD 1Y -10.4%
SUNPHARMA.NS
SUNPHARMA.NS • India
SUN PHARMACEUTICAL IND L
1,760 INR
43.63B USD 1Y +7.9%
3692.HK
3692.HK • China
HANSOH PHARMA
31.54 HKD
24.37B USD 1Y -14.8%
4502.T
4502.T • Japan
TAKEDA PHARMACEUTICAL CO LTD
5,843 JPY
58.98B USD 1Y +34.8%
TAK
TAK • Japan
Takeda Pharmaceutical Company L
18.73 USD
59.83B USD 1Y +29.4%
002001.SZ
002001.SZ • China
NHU
26.58 CNY
12.22B USD 1Y +6.1%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
3Y Volatility
-
Max Drawdown (3Y)
-
Sharpe Ratio (3Y)
-
Beta Factor
0.04
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
ende